<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T08:06:42Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/5881" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/5881</identifier><datestamp>2025-10-24T10:43:39Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Patients with Moderate to Severe Psoriasis Associate with Higher Risk of Depression and Anxiety Symptoms: Results of a Multivariate Study of 300 Spanish Individuals with Psoriasis</dc:title>
   <dc:creator>Tribó, Maria José</dc:creator>
   <dc:creator>Turroja, Marta</dc:creator>
   <dc:creator>Castaño-Vinyals, Gemma</dc:creator>
   <dc:creator>Bulbena, Antonio</dc:creator>
   <dc:creator>Ros Cucurull, Elena</dc:creator>
   <dc:creator>García-Martínez, Pablo</dc:creator>
   <dc:contributor>Institut Català de la Salut</dc:contributor>
   <dc:contributor>[Tribó MJ, Turroja M, García-Martínez P] Department of Dermatology. [Castaño-Vinyals G] ISGlobal. CIBER Epidemiología y Salud Pública (CIBERESP), Madrid. [Bulbena A] Department of Psychiatry, Parc de Salut Mar. [Ros E] Servei de Psiquiatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Psoriasi</dc:subject>
   <dc:subject>Humor (Psicologia)</dc:subject>
   <dc:subject>Qüestionaris</dc:subject>
   <dc:subject>DISEASES::Skin and Connective Tissue Diseases::Skin Diseases::Skin Diseases, Papulosquamous::Psoriasis</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::/psychology</dc:subject>
   <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires</dc:subject>
   <dc:subject>ENFERMEDADES::enfermedades de la piel y tejido conjuntivo::enfermedades de la piel::enfermedades cutáneas papuloescamosas::psoriasis</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::/psicología</dc:subject>
   <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios</dc:subject>
   <dc:description>Psoriasi: Ansietat; Depressió</dc:description>
   <dc:description>Psoriasis; Anxiety; Depression</dc:description>
   <dc:description>Psoriasis; Ansiedad; Depresión</dc:description>
   <dc:description>Psoriasis is a chronic skin disease associated with considerable physical and psychological comorbidities. Stress and emotional disturbances have been implicated in both triggering the onset and exacerbation of psoriasis. In order to determine the level of perceived stress and mood alterations in patients with psoriasis and their association with disease severity, 300 individuals completed diverse validated questionnaires assessing stress and psychological mood. Evaluation of perception of disease was also measured. A significant association between psoriasis severity and mood, emotional disturbances and an impact on assessments of the quality of life were observed. Particularly, Montgomery-Asberg Depression Rating Scale, Hamilton Rating Scale and Hospital Anxiety and Depression Scale for Depression detected a significant risk for depression in relation to the disease severity. The association between depression features, anxiety and perceived stress with psoriasis severity is important and can influence the appropriate management of psoriasis.</dc:description>
   <dc:description>This study was supported by grant “Agència d’ Avaluació de Tecnologia i Recerca Mèdiques” (AATM project 1892/I/04), Generalitat de Catalunya, Barcelona, Spain.</dc:description>
   <dc:date>2021-04-20T12:21:29Z</dc:date>
   <dc:date>2021-04-20T12:21:29Z</dc:date>
   <dc:date>2019-04-01</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Tribó MJ, Turroja M, Castaño-Vinyals G, Bulbena A, Ros E, García-Martínez P, et al. Patients with moderate to severe psoriasis associate with higher risk of depression and anxiety symptoms: Results of a multivariate study of 300 Spanish individuals with psoriasis. Acta Derm Venereol. 2019 Apr 1;99(4):417–22.</dc:identifier>
   <dc:identifier>1651-2057</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/5881</dc:identifier>
   <dc:identifier>10.2340/00015555-3114</dc:identifier>
   <dc:identifier>30628634</dc:identifier>
   <dc:identifier>000462132400010</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/5881</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Acta Dermato-Venereologica;99(4)</dc:relation>
   <dc:relation>https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-3114</dc:relation>
   <dc:rights>Attribution-NonCommercial 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Acta Dermato-Venereologica</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>